Co-Authors
This is a "connection" page, showing publications co-authored by Jiqian Xu and Xiaojing Zou.
Connection Strength
0.794
-
A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure. Front Med (Lausanne). 2020; 7:607821.
Score: 0.229
-
Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China. Crit Care. 2020 07 06; 24(1):394.
Score: 0.223
-
The peak levels of highly sensitive troponin I predicts in-hospital mortality in COVID-19 patients with cardiac injury: a retrospective study. Eur Heart J Acute Cardiovasc Care. 2021 Mar 05; 10(1):6-15.
Score: 0.058
-
Extracorporeal Membrane Oxygenation for SARS-CoV-2 Acute Respiratory Distress Syndrome: A Retrospective Study From Hubei, China. Front Med (Lausanne). 2020; 7:611460.
Score: 0.058
-
Imaging Mass Cytometric Analysis of Postmortem Tissues Reveals Dysregulated Immune Cell and Cytokine Responses in Multiple Organs of COVID-19 Patients. Front Microbiol. 2020; 11:600989.
Score: 0.058
-
Tracheostomy in 80 COVID-19 Patients: A Multicenter, Retrospective, Observational Study. Front Med (Lausanne). 2020; 7:615845.
Score: 0.057
-
Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19. Immunity. 2020 11 17; 53(5):1108-1122.e5.
Score: 0.057
-
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 05; 8(5):475-481.
Score: 0.054